Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...

Newborn screening programme for sickle cell disease (SCD), undertaken between 2019-2024, reduced mortality risk to below 5 ...

Deion Sanders missed CU football camps required by contract. Fans question his absence, but health issues may explain it.

Identifying new drugs for patients with sickle cell disease is very important, said a senior scientist at the Indian Council ...

Stay informed on health matters with Zubeda Hamid's newsletter covering cataract surgeries, maternal health, and medical ...

Foundation, a nonprofit organization dedicated to providing free life-saving medicines and essential support to individuals ...

This might help: The analyst community's current consensus price target of $77.21 is about 75% above this stock's present price. Finally, add Confluent ( CFLT -0.13%) to your list of the best stocks ...

Vertex Pharmaceuticals locked arms with Ono Pharmaceutical in an exclusive deal to advance povetacicept, targeting B ...

Bristol-Myers Squibb has secured a pivotal FDA orphan drug designation for its sickle cell disease treatment, signaling a ...

Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...

The TSA Warns Against 'Juice Jacking' at the Airport—Here's How to Protect Yourself What temperature to set your thermostat ...